The United States Court of International Trade recently issued an opinion on whether a company in Washington state could import drug paraphernalia, specifically cannabis-trimming equipment. That case, Eteros Technologies USA vs. United States, concerns “the interplay between the federal and state systems, specifically the Washington State system, governing


Continue Reading Cannabis Paraphernalia: Custom and Border Protection Loses Case

The United States Food and Drug Administration (FDA) has consistently taken the position that cannabidiol derived from hemp (CBD) cannot be marketed or sold as a dietary supplement or food. The FDA’s position is based on the fact that CBD has been approved for use in a pharmaceutical drug and


Continue Reading The FDA is Quietly Targeting CBD in 2022